Flputnam Investment Management Co. Sells 4,388 Shares of Agilent Technologies, Inc. $A

Key Points

• Flputnam Investment Management Co. reduced its stake in Agilent Technologies by 6.8%, now holding 60,005 shares valued at approximately $7 million after selling 4,388 shares in the first quarter.
• Agilent reported $1.74 billion in revenue for the most recent quarter, exceeding analyst expectations of $1.67 billion, and its earnings per share met the consensus estimate of $1.37.
• The stock currently has a consensus rating of "Moderate Buy" with analyst price targets ranging from $128.00 to $155.00, reflecting mixed outlooks on its future performance.

Flputnam Investment Management Co. lowered its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 6.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 60,005 shares of the medical research company's stock after selling 4,388 shares during the period. Flputnam Investment Management Co.'s holdings in Agilent Technologies were worth $7,019,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC lifted its stake in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after purchasing an additional 186 shares during the period. Sunbelt Securities Inc. lifted its stake in shares of Agilent Technologies by 640.0% in the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares during the period. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $30,000. Opal Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $31,000. Finally, Wood Tarver Financial Group LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $34,000.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on A. TD Cowen boosted their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Barclays reaffirmed an "equal weight" rating and set a $125.00 price target on shares of Agilent Technologies in a research note on Friday, August 29th. Evercore ISI dropped their price target on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research note on Thursday, August 28th. Finally, Wells Fargo & Company upped their price target on Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Thursday, August 28th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and a consensus price target of $139.25.

Agilent Technologies Stock Up 0.2%

A stock traded up $0.21 during trading on Friday, reaching $128.69. 1,633,203 shares of the stock were exchanged, compared to its average volume of 1,522,644. The firm has a market cap of $36.48 billion, a P/E ratio of 30.21, a price-to-earnings-growth ratio of 4.00 and a beta of 1.24. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The firm's 50 day moving average is $119.22 and its 200 day moving average is $116.34. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.